海南海藥(000566.SZ):與純良農業簽署戰略合作框架協議 共同做大、做強、做優“雲當歸”和“雲木香”道地中藥材品牌
格隆匯12月3日丨海南海藥(000566.SZ)公佈,為響應黨中央打響全國全面脱貧攻堅戰和促進中藥材產業高質量發展的號召,做強中醫藥產業並帶動地區經濟發展,在迪慶州農牧業局和維西縣投資促進局的倡導下,公司控股子公司湖南廉橋藥都醫藥有限公司(“廉橋藥都”)和維西縣純良農業科技有限公司(“純良農業”)簽署戰略合作框架協議,擬在維西縣域內共建特色中藥材種植基地,共同做大、做強、做優“雲當歸”和“雲木香”道地中藥材品牌。
雙方擬於2020年—2024年期間,在迪慶藏族自治州維西傈僳族自治縣永春鄉拖枝村、果咱底村、鍋底塘村境內建設總面積約12000畝的中藥材種植基地,由維西縣純良農業科技有限公司負責選址、組織生產並提供種苗,主要種植雲南維西傳統優勢品種“雲當歸”、“雲木香”。
此次戰略合作框架協議的簽署,有益於雙方在中藥材產品的品牌建設、規範化種苗培育、原藥種植、初加工、檢驗檢測、倉儲物流、渠道對接、成品製售等領域發揮各自優勢,共同將中藥材產業做大、做強、做優,符合公司戰略發展的需要,有利於公司長遠發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.